The Linkou Chang Gung Memorial Hospital also known as Chang Gung Memorial Hospital or "Chang Gung Hospital", is a hospital located in Guishan District, Taoyuan City, Taiwan. It is part of the Chang Gung Medical Foundation hospital network.

During the past decade, Chang Gung Memorial Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chang Gung Memorial Hospital" #1 sponsor was "Chang Gung Memorial Hospital" with 6 trials, followed by "Mel Shiuann-Sheng Lee" with 2 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored, "AVEO Pharmaceuticals, Inc." with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chang Gung Memorial Hospital" #1 collaborator was "National Science Council, Taiwan" with 2 trials as a collaborator, "Biodesix, Inc." with 1 trials as a collaborator, "Johnson & Johnson" with 1 trials as a collaborator, "Ministry of Science and Technology, Taiwan" with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Chang Gung Memorial Hospital" are "Non-small Cell Lung Cancer" (2 trials), "Arthroplasty, Replacement, Hip" (1 trials), "Dual-Energy X-Ray Absorptiometry" (1 trials), "Fecal Incontinence" (1 trials) and "Functional Outcomes" (1 trials). Many other conditions were trialed in "Chang Gung Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Chang Gung Memorial Hospital" are "Drug" (5 trials), "Procedure" (4 trials), "Other" (3 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Aclasta" (1 trials), "Androgen Deprivation Therapy (ADT)" (1 trials), "Conservative treatment" (1 trials) and "Enzalutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chang Gung Memorial Hospital" are 10 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Chang Gung Memorial Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Chang Gung Memorial Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Chang Gung Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".